, Volume 89, Issue 3, pp 400-402
Date: 31 Mar 2009

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access